Chenbin Bian
Overview
Explore the profile of Chenbin Bian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bian C, Zheng Z, Su J, Chang S, Yu H, Bao J, et al.
Front Pharmacol
. 2024 Nov;
15:1394754.
PMID: 39568579
Objectives: Literature data are scarce on concurrent chemoradiotherapy (CCRT) with S-1 for locally advanced nasopharyngeal carcinoma (LANPC) treatment. This study compared the efficacy and safety of the S-1 platinum-based CCRT...
2.
Chang S, Lv J, Wang X, Su J, Bian C, Zheng Z, et al.
Crit Rev Oncol Hematol
. 2024 Aug;
202:104461.
PMID: 39103129
The treatment of thoracic tumors with ionizing radiation can cause radiation-induced lung injury (RILI), which includes radiation pneumonitis and radiation-induced pulmonary fibrosis. Preventing RILI is crucial for controlling tumor growth...
3.
Wang H, Zheng Z, Zhang Y, Bian C, Bao J, Xin Y, et al.
Front Pharmacol
. 2023 Oct;
14:1269863.
PMID: 37795033
Head and neck squamous cell carcinoma (HNSCC) accounts for approximately 3% of new cancer cases and 3% of all deaths worldwide. Most HNSCC patients are locally advanced (LA) at diagnosis....
4.
Bian C, Zheng Z, Su J, Chang S, Yu H, Bao J, et al.
Front Pharmacol
. 2023 Sep;
14:1271613.
PMID: 37767404
Copper is an indispensable micronutrient for the development and replication of all eukaryotes, and its redox properties are both harmful and beneficial to cells. An imbalance in copper homeostasis is...
5.
Su J, Zheng Z, Bian C, Chang S, Bao J, Yu H, et al.
Front Immunol
. 2023 Aug;
14:1253064.
PMID: 37646027
As critical executors regulating many cellular operations, proteins determine whether living activities can be performed in an orderly and efficient manner. Precursor proteins are inert and must be modified posttranslationally...
6.
Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy
Zheng Z, Su J, Bao X, Wang H, Bian C, Zhao Q, et al.
Front Immunol
. 2023 Aug;
14:1247268.
PMID: 37600785
Radiotherapy (RT) is an effective treatment option for cancer patients, which induces the production of reactive oxygen species (ROS) and causes oxidative stress (OS), leading to the death of tumor...
7.
Zhang M, Ding Q, Bian C, Su J, Xin Y, Jiang X
Exp Cell Res
. 2023 Mar;
426(1):113563.
PMID: 36944406
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors, with poor prognosis and high mortality. Early-stage HCC has no obvious clinical symptoms, and most patients are already at...
8.
Zheng Z, Bian C, Wang H, Su J, Meng L, Xin Y, et al.
Ther Adv Med Oncol
. 2022 Nov;
14:17588359221138383.
PMID: 36425871
Immunotherapy has been used in the clinical treatment of colorectal cancer (CRC); however, most patients fail to achieve satisfactory survival benefits. Biomarkers with high specificity and sensitivity are being increasingly...
9.
Wang H, Wang B, Wei J, Zheng Z, Su J, Bian C, et al.
Life Sci
. 2022 Nov;
311(Pt B):121197.
PMID: 36400201
Aims: This study aimed to examine the efficacy of sulforaphane (SFN) in preventing radiation-induced muscle fibrosis (RIMF) and the potential role in nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated antioxidant...
10.
Bian C, Zheng Z, Su J, Wang H, Chang S, Xin Y, et al.
Antioxidants (Basel)
. 2022 Nov;
11(11).
PMID: 36358574
Radiotherapy failure and poor tumor prognosis are primarily attributed to radioresistance. Improving the curative effect of radiotherapy and delaying cancer progression have become difficult problems for clinicians. Glucose metabolism has...